Arcturus Therapeutics Holdings Inc. (ARCT) stock
ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/304% below fair value
$8.44−0.87 (-9.34%)
Close on Nov 12, 2026Market cap $239.89MP/E –Yield –
Arcturus Therapeutics statistics
77 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 2, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 1.42
- 2.29
Enterprise valuationIndustry
- EV / Sales
- 1.80
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 4.50%
- 10.9%
- Shares Change (QoQ)
- 0.13%
- 0.51%
- Float
- 26M
- 49M
- Shares Held by Insiders
- 8.05%
- 12.1%
- Shares Held by Institutions
- 87.9%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- -0.92%
- -0.76%
- Short % of Float
- 20.7%
- 9.04%
- Short % of Shares Outstanding
- 19.0%
- 6.30%
- Days to Cover
- 7.37
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $17.96
- –
- 52-Week Low
- $5.50
- –
- 20-Day Moving Average
- $10.30
- –
- 50-Day Moving Average
- $12.57
- –
- 200-Day Moving Average
- $9.10
- –
- Average True Range (14)
- $1.11
- –
- Price Change (1 Week)
- -9.83%
- 1.51%
- Price Change (1 Month)
- -24.1%
- -2.35%
- Price Change (3 Months)
- 2.55%
- -21.1%
- Price Change (6 Months)
- 7.79%
- -22.6%
- Price Change (YTD)
- 37.7%
- -22.6%
- Price Change (1 Year)
- -2.65%
- -20.7%
- Price Change (3 Years)
- -52.3%
- -27.4%
- Price Change (5 Years)
- -77.5%
- -77.3%
- Price Change (10 Years)
- -37.8%
- -62.7%
- Average Volume (10 Days)
- 791,039
- –
- Average Volume (20 Days)
- 712,474
- –
- Average Volume (90 Days)
- 863,149
- –
- Relative Volume
- 0.50
- 0.79
- Relative Strength Index (14)
- 37.3
- 44.7
- Volatility (1 Year)
- 82.6%
- 80.4%
- Beta (5 Years)
- 2.14
- 1.07
MarginsIndustry
- EBITDA Margin
- -302.9%
- -27.7%
- FCF Margin
- -204.7%
- -9.20%
Returns on capitalIndustry
- Return on Equity (ROE)
- -44.4%
- -51.2%
- Return on Assets (ROA)
- -35.1%
- -40.6%
- Return on Invested Capital (ROIC)
- -533.8%
- -32.9%
- Return on Capital Employed (ROCE)
- -50.8%
- -38.0%
Financial positionIndustry
- Current Ratio
- 6.68
- 3.30
- Quick Ratio
- 6.56
- 2.42
GrowthIndustry
- Revenue Growth (YoY)
- -68.7%
- 7.01%
- Revenue Growth (3Y CAGR)
- -26.4%
- 2.25%
- Revenue Growth (5Y CAGR)
- 53.8%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.12
- 0.40
- Revenue Per Employee
- $274.89K
- $429.29K
- Profits Per Employee
- -$785.96K
- -$683.67K
- Employee Count
- 111
- 75
- WACC
- 15.7%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $184.82M
- $17.46M
- Net Cash Per Share
- $6.50
- $0.72
- Equity (Book Value)
- $168.73M
- $53.27M
- Book Value Per Share
- $5.94
- $1.50
- Tangible Book Value
- $168.73M
- $26.82M
- Working Capital
- $161.05M
- $79.47M
Cash flow (TTM)Industry
- Capital Expenditures
- $36.00K
- -$944.00K
- FCF Per Share
- -$2.20
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -36.4%
- -20.8%
- FCF Yield
- -26.0%
- -9.58%
Scores and fair valueIndustry
- Altman Z-Score
- -1.05
- 0.30
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | ARCT | S&P 500 | Difference | ARCT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -33.1% | -2.7% | −30.4 pts | ||
| 3 months | +11.1% | -1.7% | +12.8 pts | ||
| Year to date | +37.7% | +11.9% | +25.8 pts | ||
| 1 year | +3.8% | +12.0% | −8.2 pts | ||
| 3 years | -55.9% | +78.2% | −134.1 pts | -23.9% | +21.2% |
| 5 years | -77.5% | +73.2% | −150.8 pts | -25.8% | +11.6% |
| 10 years | -37.8% | +309.6% | −347.5 pts | -4.6% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M ARCT shares were sold short on Oct 30, 2026, down 0.9% from the previous report, or 20.70% of the shares available to trade. At recent volumes it would take 7.4 days to buy them back. Over the last 20 sessions, 59.8% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,409,475 | -0.9% | 734,287 | 7.4 |
| Oct 15, 2026 | 5,459,944 | +1.5% | 653,118 | 8.4 |
| Sep 30, 2026 | 5,378,106 | -1.6% | 906,911 | 5.9 |
| Sep 15, 2026 | 5,467,974 | -10.3% | 858,221 | 6.4 |
| Aug 31, 2026 | 6,096,901 | -6.6% | 1,989,316 | 3.1 |
| Aug 14, 2026 | 6,526,090 | -9.4% | 661,601 | 9.9 |
| Jul 31, 2026 | 7,206,773 | +2.9% | 436,372 | 16.5 |
| Jul 15, 2026 | 7,004,482 | +3.0% | 654,282 | 10.7 |
| Jun 30, 2026 | 6,801,943 | +1.4% | 439,741 | 15.5 |
| Jun 15, 2026 | 6,708,681 | -0.3% | 378,532 | 17.7 |
| May 29, 2026 | 6,728,068 | +2.3% | 410,680 | 16.4 |
| May 15, 2026 | 6,574,536 | +2.1% | 495,602 | 13.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?